[Risk factors for extrauterine growth restriction in preterm infants with gestational age less than 34 weeks]

Wei Cao1, Yong-Hong Zhang, Dong-Ying Zhao

  • 1Department of Neonatalogy, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China. xlj68115@aliyun.com.

Insights

Extrauterine growth restriction (EUGR) affects 40.9% of preterm infants born before 34 weeks. Factors like intrauterine growth restriction (IUGR) and very low birth weight (VLBW) increase EUGR risk, necessitating early nutritional support.

Area of Science:

  • Neonatology
  • Pediatric Nutrition
  • Growth Monitoring

Context:

  • Preterm infants (<34 weeks gestation) are vulnerable to extrauterine growth restriction (EUGR).
  • Understanding factors contributing to EUGR is crucial for improving outcomes in this population.

Purpose:

  • To identify correlated factors associated with extrauterine growth restriction (EUGR) in preterm infants (gestational age <34 weeks).

Summary:

  • A study of 694 preterm infants found EUGR in 40.9%. Higher incidence observed in infants with intrauterine growth restriction (IUGR) and very low birth weight (VLBW).
  • Delayed feeding, prolonged parenteral nutrition, and increased nutritional deficits were linked to EUGR.
  • Increased risks of respiratory distress syndrome, apnea, necrotizing enterocolitis, and septicemia were noted in the EUGR group.
  • Independent risk factors for EUGR included lower birth weight, reduced gestational age, and IUGR.

Impact:

  • Findings highlight the high incidence of EUGR in preterm infants, particularly those with IUGR or VLBW.
  • Suggests that early, aggressive nutritional strategies and prevention of common morbidities like apnea and septicemia are vital for reducing EUGR.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
209
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.5K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
434
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K